Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus

Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus

Abstract Encephalomyocarditis virus (EMCV), a potential zoonotic pathogen, poses significant socioeconomic and public health challenges across various host species. Although EMCV rarely triggers severe clinical symptoms in humans, its widespread prevalence and unique biological characteristics under...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanfang Zhang, Zhiying Wang, Yaohui Fang, Qiong Zhu, Jie Fu, Sijing Hu, Jiayin Jin, Min Zhou, Xijia Liu, Danna Zhang, Shouwei Huang, Yali Deng, Lingling Xie, Shu Shen, Jing Ye, Fei Deng, Shengbo Cao
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Animal Diseases
Subjects:	Encephalomyocarditis virus Monoclonal antibody Virus-like particles Neutralizing activity Therapeutic efficacy Antiviral development
Online Access:	https://doi.org/10.1186/s44149-024-00154-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preparation and application of porcine broadly neutralizing monoclonal antibodies in an immunoassay for efficiently detecting neutralizing antibodies against foot-and-mouth disease virus serotype O
by: Yimei Cao, et al.
Published: (2025-02-01)

Development and evaluation of a recombinant monoclonal human antibody with virus-neutralizing activity against the F glycoprotein of respiratory syncytial virus
by: Sergey A. Klotchenko, et al.
Published: (2024-12-01)

Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2024-10-01)

Characterization of two neutralizing monoclonal antibodies with conformational epitopes against porcine deltacoronavirus
by: Wan Lu, et al.
Published: (2025-01-01)

Corrigendum: Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2025-02-01)

A Comprehensive Review of the Development and Therapeutic Use of Antivirals in Flavivirus Infection
by: Aarti Tripathi, et al.
Published: (2025-01-01)

Preparation and application evaluation of monoclonal antibodies against Monkeypox virus A29 protein
by: Ai Xiangjun, et al.
Published: (2025-01-01)

TRIM8 inhibits porcine epidemic diarrhoea virus replication by targeting and ubiquitinately degrading the nucleocapsid protein
by: Zhenbin Bi, et al.
Published: (2025-01-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Formulation and optimization of polymeric nanoparticles loaded with riolozatrione: a promising nanoformulation with potential antiherpetic activity
by: Solís-Cruz Guadalupe Y., et al.
Published: (2023-09-01)

Anti-HSV-1 agents: an update
by: Wenwen Lv, et al.
Published: (2025-01-01)

Characteristics of the monkeypox virus isolate obtained from the first patient in Russia and its sensitivity to 7-[N-(4-trifluoromethylbenzoyl)-hydrazinocarbonyl]-tricyclo-[3.2.2.0^2,4]non-8-en-6-carboxylic acid
by: Alena S. Ovchinnikova, et al.
Published: (2024-12-01)

Cost-savings and health impact of strategies for prevention of Respiratory Syncytial Virus with nirsevimab in Chile based on the integrated analysis of 2019–2023 national databases: A retrospective study
by: Denis Sauré, et al.
Published: (2025-04-01)

Flunarizine as a Candidate for Drug Repurposing Against Human Pathogenic Mammarenaviruses
by: Chukwudi A. Ofodile, et al.
Published: (2025-01-01)

How to use monoclonal antibody-based therapy in ALL
by: Erica Brivio, et al.
Published: (2025-06-01)

Advances and Challenges in Antiviral Development for Respiratory Viruses
by: Luis Adrián De Jesús-González, et al.
Published: (2024-12-01)

Decitabine Increases the Transcription of <i>RIG-I</i> Gene to Suppress the Replication of Feline Calicivirus and Canine Influenza Virus
by: Shaotang Ye, et al.
Published: (2025-01-01)

Single monoclonal spike characterized as double monoclonal gammopathy in a patient with multiple myeloma: A rare finding
by: Rajni Saijpaul, et al.
Published: (2023-01-01)

Regulation of viral replication by host restriction factors
by: Ying Lin, et al.
Published: (2025-01-01)

Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01)

Study of humoral immunity in animals immunized with emulsion FMD vaccines
by: S. R. Kremenchugskaya, et al.
Published: (2018-04-01)

The Strategies Used by Animal Viruses to Antagonize Host Antiviral Innate Immunity: New Clues for Developing Live Attenuated Vaccines (LAVs)
by: Na Chen, et al.
Published: (2025-01-01)

HDAC6 Facilitates PRV and VSV Infection by Inhibiting Type I Interferon Production
by: Hu Zheng, et al.
Published: (2025-01-01)

Standardization, validation, and comparative evaluation of a convenient surrogate recombinant vesicular stomatitis virus plaque reduction test for quantification of Hantaan orthohantavirus (HTNV) neutralizing antibodies
by: Jing Wei, et al.
Published: (2025-02-01)

Exploiting venom toxins in paratransgenesis to prevent mosquito-borne disease
by: Stephanie French, et al.
Published: (2025-01-01)

Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial
by: Chaoying Hu, et al.
Published: (2024-12-01)

Studies on development of early immunity against type O FMD in naturally susceptible animals
by: D. V. Mikhalishin, et al.
Published: (2020-06-01)

Studies on humoral immunity in dogs after use of rabies inactivated vaccines formulated with Montanide ISA 70 VG and GEL 01 adjuvants
by: A. N. Balashov, et al.
Published: (2020-03-01)

Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1
by: N. B. Rudometova, et al.
Published: (2022-04-01)

Newcastle Disease Virus Displaying an Ectodomain of Middle East Respiratory Syndrome Coronavirus Spike Protein Elicited Robust Humoral and Cellular Immunity in Mice
by: Jaturawitt Prasopsiri, et al.
Published: (2024-12-01)

Selective suppression of influenza A/H5N1 virus replication <i>in vitro</i> using nanocomplexes consisting of siRNA and aminopropylsilanol nanoparticles
by: Marina N. Repkova, et al.
Published: (2024-12-01)

HDAC1 and HDAC2 Are Involved in Influenza A Virus-Induced Nuclear Translocation of Ectopically Expressed STAT3-GFP
by: Jessica Leong, et al.
Published: (2024-12-01)

Association of hepatitis B virus DNA levels with efficacy and safety and the impact of antiviral therapy on prognosis in liver cancer patients receiving immune checkpoint inhibitors therapy: a systematic review and meta-analysis
by: Hongxia Cui, et al.
Published: (2025-01-01)

Learn from international recommendations and experiences of countries that have successfully implemented monoclonal antibody prophylaxis for prevention of RSV infection
by: Sara Manti, et al.
Published: (2025-02-01)

Concurrent presentation of proliferative glomerulonephritis with monoclonal immunoglobulin deposits and light chain proximal tubulopathy: a case report and review of the literature
by: Jingdong Zhang, et al.
Published: (2025-01-01)

Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
by: Mingya Cao, et al.
Published: (2025-01-01)

Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses
by: Thomas J. Baric, et al.
Published: (2024-12-01)

Current Views of Torque Teno Virus (TTV) in Liver Diseases
by: I. V. Maev, et al.
Published: (2020-09-01)

Concentration of viruses and electron microscopy
by: I. D. Petrova, et al.
Published: (2020-05-01)

Rose Mosaic Virus Disease: A Disease Caused by a Virus Complex and Symptoms on Roses and Management Practices
by: Susannah da Silva, et al.
Published: (2018-08-01)